Wesley Kaupinen; President, Chief Executive Officer; Palvella Therapeutics Inc. Jeffrey Martini; Chief Scientific Officer; Palvella Therapeutics Inc. Presentation. O ...

Palvella Therapeutics Inc. Phase 3 SELVA trial evaluating QTORIN™ 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin) for the ...

Cerebrovascular disease affects blood flow to the brain, increasing stroke risk. Learn about its different types, causes, ...

Lucknow boy undergoes renal re-transplant with innovative venous pathway reuse by expert team at private hospital.

CAMBRIDGE, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining ...

Causes of ischemic stroke include atrial fibrillation, atherosclerosis, clotting disorders, and severe infection, while hemorrhagic stroke is more commonly caused by severe high blood pressure, head ...

More information: Roberto Guzmán‐Hernández et al, Fibrillar tau alters cerebral endothelial cell metabolism, vascular inflammatory activation, and barrier function in vitro and in vivo ...

Restrepo has a rare facial condition, vascular malformation, which he developed soon after birth, resulting in a distinct malformation of his lips. Per his mother, Ashley, at the time of his birth ...

He's also been candid about his experiences living with vascular malformation, a rare condition that can cause abnormal blood flow into the left side of his face. With that, here's what you need ...

Cerebral arteriovenous malformations (AVMs) are an uncommon type of central nervous system vascular anomaly that have the potential to rupture and cause intracranial hemorrhage. AVM hemorrhagic risk ...

Overall, we recommend the use of rodent and swine models for the study of brain arteriovenous malformation and intracerebral aneurysm due to their respective accessibility and reliability when ...